Skip to main content

Want a detailed portfolio tracker?

CorMedix (CRMD) P/E (2011 - 2026)

CorMedix (CRMD) P/E from Mar 31, 2011 to Jul 20, 2026. The TTM CorMedix (CRMD) P/E is 3.35. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of CorMedix (CRMD)

YearP/EChange
20263.35-38.51%
20255.45-124.12%
2024-22.60+412.83%
2023-4.41-23.00%
2022-5.72-6.79%
2021-6.14-38.05%
2020-9.91-10.39%
2019-11.06+165.11%
2018-4.17+396.68%
2017-0.84-68.22%
2016-2.64-27.25%
2015-3.63+75.88%
2014-2.07-22.10%
2013-2.65+55.62%
2012-1.70+273.55%
2011-0.46N/A

Comparison CorMedix (CRMD) P/E with competitors

CorMedix (CRMD) P/E is 3.35.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.95%
NBYStablecoin Development Corp0.00-99.87%
ENLVEnlivex Ltd0.07-97.77%
FGENFibroGen Inc0.24-92.84%
CHRSCoherus Biosciences Inc0.85-74.69%
FBIOFortress Biotech Inc0.95-71.69%
ORMPOramed Pharmaceuticals Inc1.50-55.17%
AGENAgenus Inc3.01-10.23%
INVAInnoviva Inc3.15-5.93%
VXRTVaxart Inc3.55+5.88%
CVACCureVac N.V.4.45+32.60%
GLPGGalapagos NV4.86+44.92%
SRPTSarepta Therapeutics Inc4.88+45.62%
ABEOAbeona Therapeutics Inc5.39+60.69%
ABUSArbutus Biopharma Corp5.60+66.90%
ZVRAZevra Therapeutics Inc5.89+75.60%
SPROSpero Therapeutics Inc6.23+85.77%
CGENCompugen Ltd6.31+88.32%
RIGLRigel Pharmaceuticals6.87+104.97%
SLXNSilexion Therapeutics Corp7.30+117.62%
OMEROmeros Corporation9.26+176.16%
AUPHAurinia Pharmaceuticals Inc9.58+185.89%
PLXProtalix BioTherapeutics Inc10.89+224.84%
ACADAcadia Pharmaceuticals Inc11.73+249.82%
TBPHTheravance Biopharma Inc12.26+265.74%
ADMAAdma Biologics Inc12.42+270.39%
HRMYHarmony Biosciences Holdings Inc13.82+312.21%
SABSSAB Biotherapeutics Inc14.14+321.64%
NAGENiagen Bioscience Inc14.82+341.98%
INCYIncyte Corp15.82+371.93%
REGNRegeneron Pharmaceuticals Inc15.86+372.95%
PBYIPuma Biotechnology Inc17.32+416.47%
CPRXCatalyst Pharmaceuticals Inc17.44+420.16%
EXELExelixis Inc17.54+423.10%
TGTXTG Therapeutics Inc18.97+465.70%
MDXGMimedx Group Inc20.55+513.01%
XOMAXOMA Royalty Corp22.87+582.29%
ARGXArgen X SE24.30+624.75%
CTMXCytomX Therapeutics Inc24.82+640.35%
XOMAOXOMA Royalty Corp25.34+655.97%
HALOHalozyme Therapeutics Inc25.62+664.29%
XOMAPXOMA Royalty Corp25.67+665.68%
VRTXVertex Pharmaceuticals Inc27.99+735.01%
RPRXRoyalty Pharma plc - Class A28.69+755.68%
SLNOSoleno Therapeutics Inc29.02+765.46%
ASNDAscendis Pharma A/S30.09+797.38%
LGNDLigand Pharmaceuticals Inc - Class B37.91+1030.82%
APLSApellis Pharmaceuticals Inc39.02+1063.91%
BMRNBiomarin Pharmaceutical Inc42.21+1159.07%
KRYSKrystal Biotech Inc45.34+1252.48%
ONCBeiGene Ltd69.54+1974.22%
PHARPharming Group N.V.75.03+2137.83%
TECHBio-Techne Corp101.96+2941.17%
VCELVericel Corp109.92+3178.68%
ALNYAlnylam Pharmaceuticals Inc117.96+3418.61%
GMABGenmab140.29+4084.53%
TLXTelix Pharmaceuticals Ltd162.15+4736.62%
CORTCorcept Therapeutics Inc212.86+6249.01%